Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, open-label, randomized clinical trial where patients were administered prophylaxis for total hip or knee arthroplasty either with teicoplanin or with other antibiotics. The study is aiming to evaluate any differences between these two different strategies of antimicrobial prophylaxis in the occurrence of surgical site infections

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Athens
• Collaborator: KAT Hospital of Athens
• Treatments: beta-Lactams; Cephalosporins; Ciprofloxacin; Lactams; Teicoplanin

Criteria

Inclusion Criteria:

• Patients admitted for total hip arthroplasty

• Patients admitted for total knee arthroplasty

Exclusion Criteria:

• Revision arthroplasty

• History of any infection within the preceding two months

• History of an operation in the same hip or knee for other causes

• Known history of allergy to the studied drug

• Pregnancy or lactation

• Any antibiotic therapy in the week before operation.